Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 26, 2016 - Issue 1
Submit an article Journal homepage
311
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Vitamin E derivatives: a patent review (2010 – 2015)

Maria KoufakiResearch Director, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635Athens, GreeceCorrespondence[email protected]
Pages 35-47 | Published online: 29 Oct 2015

References

  • Papers of special note have been highlighted as either of interest (*) or of considerable interest (**) to readers.
  • Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science. 1922;56:650–651.
  • Colombo ML. An update on vitamin E, tocopherol and tocotrienol-perspectives. Molecules. 2010;15:2103–2113.
  • Burton GW, Ingold KU. Vitamin E – application of the principles of physical organic-chemistry to the exploration of its structure and function. Acc Chem Res. 1986;19:194–201.
  • van Acker SABE, Koymans LMH, Bast A. Molecular pharmacology of vitamin E: structural aspects of antioxidant activity. Free Radic Biol Med. 1993;15:311–328.
  • Niki E. Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic Biol Med. 2014;66:3–12.
  • Atkinson J, Epand RF, Epand RM. Tocopherols and tocotrienols in membranes: A critical review. Free Radic Biol Med. 2008;44:739–764.
  • Jiang Q. Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med. 2014;72:76–90.

*Recent review on vitamin E family.

*Important review on non-antioxidant activities of α-tocopherol

  • Andreadou I, Iliodromitis EK, Tsovolas K, et al. Acute administration of vitamin E triggers preconditioning via K-ATP channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med. 2006;41:1092–1099.
  • Trost BM, Shen HC, Dong L, et al. Synthesis of chiral chromans by the Pd-catalyzed asymmetric allylic alkylation (AAA): scope, mechanism, and applications. J Am Chem Soc. 2004;126:11966–11983.
  • Grutter C, Alonso E, Chougnet A, et al. A biomimetic chromanol cyclization leading to alpha-tocopherol. Angew Chem Int Ed. 2006;45:1126–1130.
  • Tietze LF, Stecker F, Zinngrebe J, et al. Enantioselective palladium-catalyzed total synthesis of vitamin E by employing a domino Wacker-Heck reaction. Chem Eur J. 2006;12:8770–8776.
  • Rein C, Demel P, Outten RA, et al. Reagent directing group controlled organic synthesis: total synthesis of (R,R,R)-alpha-Tocopherol. Angew Chem Int Ed. 2007;46:8670–8673.
  • Liu KG, Chougnet A, Woggon WD. A short route to alpha-tocopherol. Angew Chem Int Ed. 2008;47:5827–5829.
  • Fuchs M, Simeo Y, Ueberbacher BT, et al. Enantiocomplementary chemoenzymatic asymmetric synthesis of (R)- and (S)-chromanemethanol. Eur J Org Chem. 2009;833–840.
  • Termath AO, Velder J, Stemmler RT, et al. Total synthesis of (2RS)-α-tocopherol through Ni-catalyzed 1,4-addition to a chromenone intermediate. Eur J Org Chem. 2014;3337–3340.
  • Uyanik M, Hayashi H, Ishihara K. High-turnover hypoiodite catalysis for asymmetric synthesis of tocopherols. Science. 2014;345:291–294.
  • Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease-Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781–786.
  • Eidelman RS, Hollar D, Hebert PR, et al. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004;164:1552–1556.
  • Shen L, Ji H-F. Vitamin E: supplement versus diet in neurodegenerative diseases. Trends Mol Med. 2012;18:443–445.
  • Jacobsen EJ, Vandoornik FJ, Ayer DE, et al. 2-(Aminomethyl) chromans that inhibit iron-dependent lipid-peroxidation and protect against central-nervous- system trauma and ischemia. J Med Chem. 1992;35:4464–4472.
  • Vajragupta O, Toasaksiri S, Boonyarat C, et al. Chroman amide and nicotinyl amide derivatives: inhibition of lipid peroxidation and protection against head trauma. Free Radic Res. 2000;32:145–155.
  • Balogh GT, Vukics K, Konczol A, et al. Nitrone derivatives of trolox as neuroprotective agents. Bioorg Med Chem Lett. 2005;15:3012–3015.
  • Koufaki M, Theodorou E, Galaris D, et al. Chroman/catechol hybrids: synthesis and evaluation of their activity against oxidative stress induced cellular damage. J Med Chem. 2006;49:300–306.
  • Koufaki M, Kiziridi C, Alexi X, et al. Design and synthesis of novel neuroprotective 1,2-dithiolane/chroman hybrids. Bioorg Med Chem. 2009;17:6432–6441.
  • Koufaki M, Theodorou E, Alexi X, et al. Synthesis of a second generation chroman/catechol hybrids and evaluation of their activity in protecting neuronal cells from oxidative stress-induced cell death. Bioorg Med Chem. 2010;18:3898–3909.
  • Koufaki M, Tsatsaroni A, Alexi X, et al. Isoxazole substituted chromans against oxidative stress-induced neuronal damage. Bioorg Med Chem. 2011;19:4841–4850.
  • Yoshioka T, Fujita T, Kanai T, et al. Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation. J Med Chem. 1989;32:421–428.
  • Reddy KA, Lohray BB, Bhushan V, et al. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives. J Med Chem. 1999;42:3265–3278.
  • Lopez GV, Batthyany C, Blanco F, et al. Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs. Bioorg Med Chem. 2005;13:5787–5796.
  • Lopez GV, Gomez LE, Campillo N, et al. Interaction studies between human alpha-tocopherol transfer protein and nitric oxide donor tocopherol analogues with LDL-protective activity. Bioorg Med Chem. 2009;17:8143–8148.
  • Astete CE, Meador DS, Spivak D, et al. Synthesis of vitamin E-carnosine (VECAR): new antioxidant molecule with potential application in atherosclerosis. Synthetic Commun. 2013;43:1299–1313.
  • Grisar JM, Marciniak G, Bolkenius FN, et al. Cardioselective ammonium, phosphonium, and sulfonium analogs of alpha-tocopherol and ascorbic-acid that in-vitro and ex-vivo lipid- peroxidation and scavenge superoxide radicals. J Med Chem. 1995;38:2880–2886.
  • Campo GM, Squadrito F, Campo S, et al. Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury. Free Radic Res. 1997;27:577–590.
  • Manfredini S, Vertuani S, Manfredi B, et al. Novel antioxidant agents deriving from molecular combinations of vitamins C and E analogues: 3,4-dihydroxy-5(R)-2(R,S)-(6-hydroxy-2,5,7,8-tetramethyl-chroman-2(R,S)-yl-methyl)- 1,3 dioxolan-4(S)-yl-5H-furan-2-one and 3-O-octadecyl derivatives. Bioorg Med Chem. 2000;8:2791–2801.
  • Koufaki M, Calogeropoulou T, Detsi A, et al. Novel potent inhibitors of lipid peroxidation with protective effects against reperfusion arrhythmias. J Med Chem. 2001;44:4300–4303.
  • Koufaki M, Calogeropoulou T, Rekka E, et al. Bifunctional agents for reperfusion arrhythmias. novel hybrid vitamin E/class I antiarrhythmics. Bioorg Med Chem. 2003;11:5209–5219.
  • Koufaki M, Detsi A, Theodorou E, et al. Synthesis of chroman analogues of lipoic acid and evaluation of their activity against reperfusion arrhythmias. Bioorg Med Chem. 2004;12:4835–4841.
  • Koufaki M, Kiziridi C, Papazafiri P, et al. Synthesis and biological evaluation of benzopyran analogues bearing class III antiarrhythmic pharmacophores. Bioorg Med Chem. 2006;14:6666–6678.
  • Koini EN, Papazafiri P. Vassilopoulos A, et al. 5,7,8-trimethyl-benzopyran and 5,7,8-trimethyl-1,4-benzoxazine aminoamide derivatives as novel antiarrhythmics against ischemia-reperfusion injury. J Med Chem. 2009;52:2328–2340.
  • Elnagar AY, Wali VB, Sylvester PW, et al. Design and preliminary structure-activity relationship of redox-silent semisynthetic tocotrienol analogues as inhibitors for breast cancer proliferation and invasion. Bioorg Med Chem. 2010;18:755–768.
  • Chen W, Park SK, Yu W, et al. Synthesis and screening of novel vitamin E derivatives for anticancer functions. Eur J Med Chem. 2012;58:72–83.
  • Salamone S, Colin C, Grillier-Vuissoz I, et al. Synthesis of new troglitazone derivatives: anti-proliferative activity in breast cancer cell lines and preliminary toxicological study. Eur J Med Chem. 2012;51:206–215.
  • Bordessa A, Colin-Cassin C, Grillier-Vuissoz I, et al. Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds. Eur J Med Chem. 2014;83:129–140.
  • Suntharalingam K, Song Y, Lippard SJ. Conjugation of vitamin E analog a-TOS to Pt(IV) complexes for dual-targeting anticancer therapy. Chem Commun. 2014;50:2465–2468.
  • Lahmann M, Thiem J. Transformations of chromanol and tocopherol and synthesis of ascorbate conjugates. Tetrahedron. 2011;67:1654–1664.
  • Koufaki M, Fotopoulou T, Kapetanou M, et al. Microwave-assisted synthesis of 3,5-disubstituted isoxazoles and evaluation of their anti-ageing activity. Eur J Med Chem. 2014;83:508–515.
  • Bebbington D, Dawson CE, Gaur S, et al. Prodrug and covalent linker strategies for the solubilization of dual-action antioxidants/iron chelators. Bioorg Med Chem Lett. 2002;12:3297–3300.
  • Isobe Y, Tobe M, Inoue Y, et al. Structure and activity relationships of novel uracil derivatives as topical anti-inflammatory agents. Bioorg Med Chem. 2003;11:4933–4940.
  • Murase H, Moon JH, Yamauchi R, et al. Antioxidant activity of a novel vitamin E derivative, 2-(alpha-D-glucopyranosyl)methyl-2,5,7,8-tetramethylchroman-6-ol. Free Radic Biol Med. 1998;24:217–225.
  • Praly JP, He L, Qin BB, et al. C-Glycopyranosyl-1,4-benzoquinones and -hydroquinones opening access to C-glycosylated analogs of vitamin E. Tetrahedron Lett. 2005;46:7081–7085.
  • He L, Galland S, Dufour C, et al. C-D-glucopyranosyl derivatives of tocopherols – synthesis and evaluation as amphiphilic antioxidants. Eur J Org Chem. 2008;1869–1883.
  • Poon J-F, Singh VP, Yan J, et al. Regenerable antioxidants-introduction of chalcogen substituents into tocopherols. Chem Eur J. 2015;21:2447–2457.
  • Li Y, Li X, Zheng W, et al. Functionalized selenium nanoparticles with nephroprotective activity, the important roles of ROS mediated signaling pathways. J Mater Chem B. 2013;1:6365–6372.
  • Viglianisi C, Di Pilla V, Menichetti S, et al. Linking an α-tocopherol derivative to cobalt(0) nanomagnets: magnetically responsive antioxidants with superior radical trapping activity and reduced cytotoxicity. Chem Eur J. 2014;20:6857–6860.
  • Duhem N, Danhier F, Pourcelle V, et al. Self-assembling doxorubicin−tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity. Bioconjugate Chem. 2014;25:72–81.
  • Palao-Suay R, Aguilar MR, Parra-Ruiz FJ, et al. Anticancer and antiangiogenic activity of surfactant-free nanoparticles based on self-assembled polymeric derivatives of vitamin E: structure-activity relationship. Biomacromolecules. 2015;16:1566–1581. DOI:10.1021/acs.biomac.5b00130.
  • Adelwohrer C, Rosenau T, Kloser E, et al. Synthesis of 5a-alpha-tocopheryl azide and its reaction to 1-(5a-alpha-tocopheryl)-1,2,3-triazols by 2+3-cycloaddition. Eur J Org Chem. 2006;2081–2086.
  • Browne EC, Langford SJ, Abbott BM. Synthesis and effects of conjugated tocopherol analogues on peptide nucleic acid hybridisation. Org Biomol Chem. 2013;11:6744–6750.
  • Ng VWL, Ke X, Lee ALZ, et al. Synergistic co-delivery of membrane-disrupting polymers with commercial antibiotics against highly opportunistic bacteria. Adv Mater. 2013;25:6730–6736.
  • Iwata R, Nishina K, Yokota T, et al. Synthesis and properties of double-stranded RNA-bindable oligodiaminogalactose derivatives conjugated with vitamin E. Bioorg Med Chem. 2014;22:1394–1403.
  • Iwata R, Nakayama F, Hirochi S, et al. Synthesis and properties of vitamin E analog-conjugated neomycin for delivery of RNAi drugs to liver cells. Bioorg Med Chem Lett. 2015;25:815–819.
  • Choi BS, Choi J, Bak S, et al. Regioselective synthesis of 1,3- and 1,2-tocopheryl glyceride ethers of carboxylic acids. Eur J Org Chem. 2015;514–524.
  • Nava P, Cecchini M, Chirico S, et al. Preparation of fluorescent tocopherols for use in protein binding and localization with the alpha-tocopherol transfer protein. Bioorg Med Chem. 2006;14:3721–3736.
  • Krumova K, Greene LE, Cosa G. Fluorogenic α-tocopherol analogue for monitoring the antioxidant status within the inner mitochondrial membrane of live cells. J Am Chem Soc. 2013;135:17135–17143.
  • Mitsubishi Gas Chemical Company, Inc. Process for production of optically active organic carboxylic acid. EP 2351729 A1. 2011.
  • Dsm Ip Assets B.V. Formation of chiral 4-chromanones using chiral pyrrolidines in the presence of ureas or thioureas. WO 2015001030 A1.
  • Dsm Ip Assets B.V. Synthesis of chromane compounds and their derivatives by a copper-catalyzed conjugate addition reaction. WO 2015059129 A1.
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Water-soluble vitamin E derivative modified fat-soluble anti-cancer drug compound and formulation, preparation method and use thereof. EP 2799438 A1. 2014.
  • Research Development Foundation. Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof. US8148424. 2012.
  • The Ohio State University Research Foundation. Antiadhesion agents. US20100267820 A1.
  • First Tech International Limited. Tocotrienol esters. WO2011097481 A1.
  • El Sayed KA, Sylvester PW, Behery FA. Tocotrienol derivatives and associated methods. US 20130165435 A1.
  • Chen C-S, Wang D, Kulp SK. Akt inactivation by tocopheryl derivatives. US20140031388 A1.
  • Université de Lorraine. Centre National de la Recherche Scientifique - CNRS Thiazolidinedione derivatives, preparation thereof and use thereof in cancer treatment. US 20140364465 A1.
  • Khondrion B.V. Chromanyl derivatives for treating mitochondrial disease. WO 2014011047 A1.
  • Sulfateq B.V. Compounds for protection of cells. WO 2014098586 A1.
  • Sabliov CM, Astete CE, Spivak D. Vitamin E conjugates, and their uses as antioxidants and prodrug delivery vehicles. US 20130210702 A1.
  • The Board of Trustees of the University of Arkansas. The United States of America Methods for making tocoflexols and analogues thereof. WO 2013176745 A1.
  • Edison Pharmaceuticals, Inc. Chroman derivatives. US 8791155. 2014.
  • COMPLEXA, INC. Nitroalkene tocopherols and analogs thereof for use in the treatment and prevention of inflammation related conditions. WO2015073527.
  • Phosphagenics Limited. Transdermal delivery patch. US 20140155495 A1.
  • Bromley PJ. Formulations of water-soluble derivatives of vitamin E and compositions containing same. US 20140271593 A1.
  • Université de Strasbourg. Centre National de la Recherche Scientifique. Iodinated products intended for a use for the medical imaging and their methods of preparation. WO 2013121284 A1.
  • Chin K-Y, Ima-Nirwana S. The effects of α-tocopherol on bone: a double-edged sword? Nutrients. 2014;6:1424–1441.
  • Kristal AR, Darke AK, Morris JS, et al. Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. J Natl Cancer Inst. 2014;106:djt456. DOI:10.1093/jnci/djt456.
  • Curtis AJ, Bullen M, Piccenna L, et al. Vitamin E supplementation and mortality in healthy people: a meta-analysis of randomised controlled trials. Cardiovasc Drug Ther. 2014;28:563–573.
  • Vrolijk MF, Opperhuizen A, Jansen EHJM, et al. The shifting perception on antioxidants: the case of vitamin E and β-carotene. Redox Biol. 2015;4:272–278.
  • Huang H, Patel PB, Salahudeen AK. Lazaroid compounds prevent early but not late stages of oxidant-induced cell injury: potential explanation for the lack of efficacy of lazaroids in clinical trials. Pharmacol Res. 2001;43:55–61.
  • Prasad KN, Edwards-Prasad J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res. 1982;42:550–555.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.